Bob Blouin, PharmD
Executive Vice Chancellor, UNC-Chapel Hill
Dr. Robert A. “Bob” Blouin serves as the provost, Chief Academic Officer and Chief Operating Officer of the university.
|
John Bamforth, PhD
Director of Eshelman Institute for Innovation at UNC Eshelman School of Pharmacy, UNC-Chapel Hill
Dr. John Bamforth oversees efforts to accelerate the creation and development of new medicines and technologies.
|
Angela Kashuba, PharmD
Dean, UNC Eshelman School of Pharmacy, John and Deborah McNeill, Jr. Distinguished Professor
Dr. Angela Kashuba serves as director of the UNC Center for AIDS Research Clinical Pharmacology and Analytical Chemistry Core.
|
Barbara Rimer, DrPH, MPH
Dean and Alumni Distinguished Professor, UNC Gillings School of Global Public Health
Dr. Barbara K. Rimer is the first woman and behavioral scientist to chair the National Cancer Institute's National Cancer Advisory Board.
|
Blossom Damania, PhD
Vice Dean for Research, UNC School of Medicine, Boshamer Distinguished Professor, Microbiology and Immunology
Dr. Blossom Damania oversees the research enterprise at the UNC School of Medicine, which brings in over $500 million in annual research funding.
|
Terry Magnuson, PhD
Kay M. & Van L. Weatherspoon Eminent Distinguished Professor, UNC Department of Genetics, UNC Vice Chancellor for Research
Dr. Terry Magnuson is the founding chair of the UNC Department of Genetics. He oversees, develops and supports UNC-Chapel Hill’s $1 billion research enterprise. |
Ralph Baric, PhD
William R. Kenan, Jr. Distinguished Professor, Department of Epidemiology, Department of Microbiology and Immunology, UNC-Chapel Hill
Dr. Ralph S. Baric has spent the past three decades as a world leader in the study of coronaviruses and is responsible for UNC-Chapel Hill’s world leadership in coronavirus research.
|
READDI is led by The University of North Carolina at Chapel Hill.
|